Rapid and Sensitive Detection of Shiga Toxin-Producing Escherichia coli from Nonenriched Stool Specimens by Real-Time PCR in Comparison to Enzyme Immunoassay and Culture
- 1 July 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (7) , 2008-2012
- https://doi.org/10.1128/jcm.02013-08
Abstract
Shiga toxin (Stx)-producing Escherichia coli (STEC) bacteria are a frequent cause of food-borne gastroenteritis, hemorrhagic colitis, and hemolytic uremic syndrome. Because antimicrobial agents are generally contraindicated in patients infected with STEC, a sensitive and specific diagnostic test with rapid turnaround is essential. Current culture methods may fail to detect non-O157 STEC. We evaluated a Stx gene real-time PCR assay using hybridization probes and the LightCycler instrument with 204 prospectively collected stool specimens, which were also tested for Stx by enzyme immunoassay (EIA) (ProSpecT STEC; Remel, Lenexa, KS) and by culturing on chromogenic agar (Chromagar O157; BD BBL, Sparks, MD). In addition, 85 archived stool specimens previously tested for Stx (by EIA) and/or E. coli O157:H7 (by culture) were tested by PCR. Sample preparation for PCR included mixing the stool in sterile water and extraction of nucleic acid using the MagNA Pure LC instrument (Roche Diagnostics). The PCR assay had 100% sensitivity and specificity compared to EIA and culture for specimens collected prospectively (4 of 204 specimens were positive) and compared to culture and/or EIA for archival specimens (42 of 85 specimens were positive). Both the EIA and PCR produced positive results from a specimen containing an O103 serotype STEC in the prospective specimens, and the PCR test detected three positive specimens that contained nonviable STEC in the archived specimens. The PCR assay demonstrated 100% sensitivity and specificity compared to EIA and/or culture and more rapid turnaround than either EIA or culture.Keywords
This publication has 36 references indexed in Scilit:
- Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile InfectionJournal of Clinical Microbiology, 2008
- Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infectionsCurrent Opinion in Gastroenterology, 2008
- Quantitative Real-Time Polymerase Chain Reaction for Evaluating DNAemia due to Cytomegalovirus, Epstein-Barr Virus, and BK Virus in Solid-Organ Transplant RecipientsClinical Infectious Diseases, 2007
- Evaluation of 5′-nuclease and hybridization probe assays for the detection of shiga toxin-producing Escherichia coli in human stoolsJournal of Microbiological Methods, 2007
- Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical ManifestationsJournal of Clinical Microbiology, 2007
- Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic SyndromeClinical Microbiology Reviews, 2004
- Evaluation of Performance and Potential Clinical Impact of ProSpecT Shiga Toxin Escherichia coli Microplate Assay for Detection of Shiga Toxin-Producing E. coli in Stool SamplesJournal of Clinical Microbiology, 2004
- Escherichia coliHarboring Shiga Toxin 2 Gene Variants: Frequency and Association with Clinical SymptomsThe Journal of Infectious Diseases, 2002
- Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Eschevichia coli infectionClinical Microbiology & Infection, 1999
- Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 InfectionsThe Journal of Infectious Diseases, 1989